267 filings
Page 8 of 14
8-K
5bc36t15kdvn
2 Apr 19
Regulation FD Disclosure
8:15am
8-K
apt3h o5h12
28 Mar 19
Heat Biologics Reports 2018 Results and Provides Corporate Update
7:35am
8-K
e9k53n
12 Mar 19
Entry into a Material Definitive Agreement
8:00am
8-K
e7eg2x0 56b6tmxnb
28 Feb 19
Regulation FD Disclosure
2:37pm
8-K
682ir 7ryotrlo7p79tf
28 Feb 19
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium
12:00am
8-K
6g2aq2oic8q
25 Feb 19
Other Events
5:01pm
8-K
iemof
14 Jan 19
Other Events
4:30pm
8-K
bziou s6mog792d
10 Jan 19
Heat Biologics Provides Clinical and Business Update
4:30pm
8-K
upg3ga6
8 Jan 19
Other Events
4:30pm
8-K
cqw54xr9e
8 Jan 19
Heat Biologics Corporate PresentationJanuary 2019
7:01am
8-K
fi5kltpxg n4rj8
3 Jan 19
Departure of Directors or Certain Officers
4:45pm
8-K
tax2zcc4texw0
26 Nov 18
Heat Biologics, Inc. Announces Closing of $13,800,000 Public Offering
5:15pm
8-K
ufy9obnn6v0bq3vz
21 Nov 18
Heat Biologics, Inc. Announces Proposed Public Offering
4:08pm
8-K
rsgfzion1t
15 Nov 18
Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update
8:15am
8-K
61us0j
2 Oct 18
Departure of Directors or Certain Officers
5:11pm
8-K
zv0iw9aeq9i4l468n3
14 Aug 18
Heat Biologics Reports Second Quarter 2018 Results and Provides Corporate Update
8:00am
8-K
cu8sdsry4r uoo8n
20 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
mgacyw 08
15 May 18
Heat Biologics Reports First Quarter 2018 Results and Provides Corporate Update
7:23am
8-K
39frtdpm6clfbjmiculd
7 May 18
Heat Biologics, Inc. Prices $18,000,000 Public Offering
5:20pm
8-K
abxf0uxj5 xoq248m
20 Apr 18
Other Events
12:00am